Skip to main content

Table 2 Clinical data of patients

From: Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients

 

n N = 67

CTC positive (%)

p-value

AR-positive CTC (%)

p-value

Total

67

37 (55)

 

16 (43)

 

 Menopausal status

  

0.40

 

0.68

premenopausal

12

7 (58)

 

4 (57)

 

 postmenopausal

53

28 (53)

 

11 (39)

 

 unknown

2

2 (100)

 

1 (50)

 

Line of treatment

  

0.75

 

0.30

 1st

26

15 (58)

 

8 (53)

 

  ≥ 2nd

41

22 (54)

 

8 (36)

 

IHC tumour type

  

0.94

 

0.56

 TNBC

10

6 (60)

 

2 (33)

 

 HR+/HER2-

55

30 (54)

 

14 (47)

 

 HR+/HER2 + a

2

1 (50)

 

0

 

Site of metastasis

  

0.65

 

0.44

 bone only

14

8 (57)

 

4 (50)

 

 other site

52

28 (54)

 

11 (39)

 

 unknown

1

1 (100)

 

1 (100)

 
  1. ascreening failure